Changes in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans

Biochim Biophys Acta Biomembr. 2017 Nov;1859(11):2224-2233. doi: 10.1016/j.bbamem.2017.08.017. Epub 2017 Sep 1.

Abstract

Fungal glucosylceramide (GlcCer) is a plasma membrane sphingolipid in which the sphingosine backbone is unsaturated in carbon position 8 (C8) and methylated in carbon position 9 (C9). Studies in the fungal pathogen, Cryptococcus neoformans, have shown that loss of GlcCer synthase activity results in complete loss of virulence in the mouse model. However, whether the loss of virulence is due to the lack of the enzyme or to the loss of the sphingolipid is not known. In this study, we used genetic engineering to alter the chemical structure of fungal GlcCer and studied its effect on fungal growth and pathogenicity. Here we show that unsaturation in C8 and methylation in C9 is required for virulence in the mouse model without affecting fungal growth in vitro or common virulence factors. However, changes in GlcCer structure led to a dramatic susceptibility to membrane stressors resulting in increased cell membrane permeability and rendering the fungal mutant unable to grow within host macrophages. Biophysical studies using synthetic vesicles containing GlcCer revealed that the saturated and unmethylated sphingolipid formed vesicles with higher lipid order that were more likely to phase separate into ordered domains. Taken together, these studies show for the first time that a specific structure of GlcCer is a major regulator of membrane permeability required for fungal pathogenicity.

Keywords: Cryptococcus; Fungi; Glucosylceramide; Infectious disease; Plasma membrane; Sphingolipid.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Biophysical Phenomena / physiology*
  • Cell Membrane / chemistry
  • Cell Membrane / physiology*
  • Cryptococcosis / mortality
  • Cryptococcosis / pathology
  • Cryptococcus neoformans / chemistry
  • Cryptococcus neoformans / genetics
  • Cryptococcus neoformans / pathogenicity*
  • Cryptococcus neoformans / ultrastructure*
  • Female
  • Glucosylceramides / chemistry*
  • Glucosylceramides / genetics
  • Mice
  • Mice, Inbred CBA
  • Organisms, Genetically Modified
  • Virulence* / genetics

Substances

  • Glucosylceramides